Non-Thesis Master's Program in Biopharmaceutics and Pharmacokinetics

EBF 604 — Clinically Significant Pharmacokinetic Drug Interactions
EBF 605 — Therapeutic Drug Monitoring
EBF 611 — Biopharmaceutical Evaluation of Quality-by-Design and Optimization Techniques in Micro- and Nanoparticulate Systems
EBF 612 — Application of Dissolution Rate Theories and Their Importance in Pharmacy
EBF 681 — Effect of Technological Parameters on Bioavailability
EBF 691 — Biopharmaceutics and Pharmacokinetics Seminars I
EBF 610 — Term Project

Thesis Master's Program in Biopharmaceutics and Pharmacokinetics

EBF 603 — Dissolution–Bioavailability–Bioequivalence
EBF 607 — Pharmacokinetics and Clinical Pharmacokinetics
EBF 622 — Bioavailability and Dosage Forms
EBF 651 — Fundamentals of Biopharmaceutics and Their Application to Solid Dosage Forms
EBF 691 — Biopharmaceutics and Pharmacokinetics Seminars I

PhD Program in Biopharmaceutics and Pharmacokinetics

EBF 706 — Biopharmaceutical Experimental Design and Optimization Techniques
EBF 707 — In Vitro–In Vivo Correlation
EBF 705 — Physiologically Based Pharmacokinetics
EBF 701 — Advanced Pharmacokinetics
EBF 702 — Biopharmaceutics and Pharmacokinetics Seminars II
EBF 703 — Pharmacokinetics and Drug Transporter Proteins
EBF 704 — Biopharmaceutics Classification System and Bioavailability/Bioequivalence